Patient Characteristics, Testing and Treatment Patterns, and Outcomes in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multinational, Real-World Study

被引：0
作者：
Cliff Molife
Katherine B. Winfree
Hollie Bailey
Yulia D’yachkova
Cameron Forshaw
Sangmi Kim
Kaisa-Leena Taipale
Tarun Puri
机构：
[1] Eli Lilly and Company,Value, Evidence, and Outcomes
[2] Lilly Corporate Center,Oncology
[3] Adelphi Real World,Lilly International Medical Affairs Oncology
[4] Statistics,undefined
[5] Eli Lilly and Company,undefined
[6] Global Patient Safety-Pharmacoepidemiology,undefined
[7] Eli Lilly and Company,undefined
[8] Value,undefined
[9] Evidence,undefined
[10] and Outcomes-International,undefined
[11] Eli Lilly and Company,undefined
[12] Eli Lilly and Company,undefined
来源：
Advances in Therapy | 2023年 / 40卷
关键词：
Advanced non-small cell lung cancer; Disease Specific Programme™; mutation; Patient-reported outcomes; Point-in-time; Real-world; Survey; Treatment patterns;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3135 / 3168
页数：33
相关论文
共 50 条
[41]   Patient-reported outcomes from FLAURA: Osimertinib versus erlotinib or gefitinib in patients with EGFR-mutated advanced non-small-cell lung cancer [J].
Leighl, Natasha B. ;
Karaseva, Nina ;
Nakagawa, Kazuhiko ;
Cho, Byoung-Chul ;
Gray, Jhanelle E. ;
Hovey, Tina ;
Walding, Andrew ;
Ryden, Anna ;
Novello, Silvia .
EUROPEAN JOURNAL OF CANCER, 2020, 125 :49-57
[42]   EGFR-mutated oncogene-addicted non-small cell lung cancer: Current trends and future prospects [J].
Soria, Jean-Charles ;
Mok, Tony S. ;
Cappuzzo, Federico ;
Jaenne, Pasi A. .
CANCER TREATMENT REVIEWS, 2012, 38 (05) :416-430
[43]   Real-world treatment patterns and outcomes for patients with non-metastatic non-small cell lung cancer: retrospective analyses in Canada, England, and Germany [J].
Greystoke, Alastair ;
Daumont, Melinda J. ;
Rault, Caroline ;
Baltus, Hannah ;
Ding, Philip Q. ;
Emanuel, Gabrielle ;
Lucherini, Stefano ;
Vo, Lien ;
Saglimbene, Valeria M. ;
Ralphs, Eleanor ;
Leal, Catia ;
Schoemaker, Minouk J. ;
Katalinic, Alexander ;
Waldmann, Annika ;
Cheung, Winson Y. .
BMC PULMONARY MEDICINE, 2025, 25 (01)
[44]   Lung Cancer Prognostic Index Performance in US Real-World Advanced Non-Small Cell Lung Cancer Patients [J].
Shah, R. ;
John, A. ;
Alexander, M. .
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) :S391-S391
[45]   Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis [J].
Hardtstock, Fraence ;
Myers, David ;
Li, Tracy ;
Cizova, Diana ;
Maywald, Ulf ;
Wilke, Thomas ;
Griesinger, Frank .
BMC CANCER, 2020, 20 (01)
[46]   Real-world experience of nivolumab in the treatment of poor performance status patients with advanced non-small cell lung cancer [J].
Abbas, M. Nazim ;
Klevansky, Myron ;
Koczwara, Bogda ;
Roy, Amitesh Chandra ;
Sukumaran, Shawgi ;
Vatandoust, Sina ;
Karapetis, Christos Stelios .
CANCER REPORTS, 2022, 5 (03)
[47]   Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer [J].
Davis, Keith L. ;
Goyal, Ravi K. ;
Able, Stephen L. ;
Brown, Jacqueline ;
Li, Li ;
Kaye, James A. .
LUNG CANCER, 2015, 87 (02) :176-185
[48]   Treatment patterns and real-world evidence for stage III non-small cell lung cancer in Central and Eastern Europe [J].
Zemanova, Milada ;
Jakopovic, Marko ;
Stanic, Karmen ;
Lazar-Poniatowska, Malgorzata ;
Vrankar, Martina ;
Rusu, Petronela ;
Ciuleanu, Tudor ;
Radosavljevic, Davorin ;
Bogos, Krisztina ;
Nawrocki, Sergiusz .
RADIOLOGY AND ONCOLOGY, 2020, 54 (04) :447-454
[49]   A real-world cohort study of first-line afatinib in patients with EGFR-mutant advanced non-small cell lung cancer in Vietnam [J].
Cam Phuong Pham ;
Thi Thai Hoa Nguyen ;
Anh Tu Do ;
Tuan Khoi Nguyen ;
Thi Anh Thu Hoang ;
Tuan Anh Le ;
Dinh Thy Hao Vuong ;
Dac Nhan Tam Nguyen ;
Van Khiem Dang ;
Thi Oanh Nguyen ;
Van Luan Pham ;
Minh Hai Nguyen ;
Thi Huyen Trang Vo ;
Hung Kien Do ;
Ha Thanh Vu ;
Thi Thuy Hang Nguyen ;
Van Thai Pham ;
Le Huy Trinh ;
Khac Dung Nguyen ;
Hoang Gia Nguyen ;
Cong Minh Truong ;
Tran Minh Chau Pham ;
Thi Bich Phuong Nguyen .
BMC Cancer, 24
[50]   A real-world cohort study of first-line afatinib in patients with EGFR-mutant advanced non-small cell lung cancer in Vietnam [J].
Pham, Cam Phuong ;
Nguyen, Thi Thai Hoa ;
Do, Anh Tu ;
Nguyen, Tuan Khoi ;
Hoang, Thi Anh Thu ;
Le, Tuan Anh ;
Vuong, Dinh Thy Hao ;
Nguyen, Dac Nhan Tam ;
Dang, Van Khiem ;
Nguyen, Thi Oanh ;
Pham, Van Luan ;
Nguyen, Minh Hai ;
Vo, Thi Huyen Trang ;
Do, Hung Kien ;
Vu, Ha Thanh ;
Nguyen, Thi Thuy Hang ;
Pham, Van Thai ;
Trinh, Le Huy ;
Nguyen, Khac Dung ;
Nguyen, Hoang Gia ;
Truong, Cong Minh ;
Pham, Tran Minh Chau ;
Nguyen, Thi Bich Phuong .
BMC CANCER, 2024, 24 (01)
12345